Bristol Myers Squibb (BMY) |
United States |
$135.392B |
9.38 |
Amgen (AMGN) |
United States |
$131.529B |
13.72 |
CSL (CSLLY) |
Australia |
$87.969B |
0.00 |
Gilead Sciences (GILD) |
United States |
$81.201B |
9.11 |
Illumina (ILMN) |
United States |
$58.192B |
88.63 |
Vertex Pharmaceuticals (VRTX) |
United States |
$55.106B |
23.42 |
Moderna (MRNA) |
United States |
$52.846B |
0.00 |
Regeneron Pharmaceuticals (REGN) |
United States |
$49.449B |
16.16 |
Biogen (BIIB) |
United States |
$41.239B |
8.25 |
Alexion Pharmaceuticals (ALXN) |
United States |
$32.999B |
12.85 |
BeiGene (BGNE) |
Cayman Islands |
$27.578B |
0.00 |
Seagen (SGEN) |
United States |
$27.057B |
46.38 |
BioNTech SE (BNTX) |
Germany |
$23.164B |
0.00 |
Genmab (GMAB) |
Denmark |
$20.811B |
29.13 |
Exact Sciences (EXAS) |
United States |
$20.568B |
0.00 |
Genmab (GNMSF) |
Denmark |
$19.984B |
4.74 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$19.862B |
22.79 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$19.827B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$17.927B |
57.05 |
Incyte (INCY) |
United States |
$17.645B |
0.00 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$16.777B |
0.00 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$14.759B |
0.00 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.134B |
112.65 |
Bio-Techne Corp (TECH) |
United States |
$13.821B |
79.16 |
Guardant Health (GH) |
United States |
$13.585B |
0.00 |
Novavax (NVAX) |
United States |
$12.913B |
0.00 |
Zai Lab (ZLAB) |
China |
$12.081B |
0.00 |
QIAGEN (QGEN) |
Netherlands |
$10.823B |
22.10 |
Repligen (RGEN) |
United States |
$10.198B |
112.16 |
Mirati Therapeutics (MRTX) |
United States |
$9.650B |
0.00 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$8.648B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$7.933B |
0.00 |
Ascendis Pharma (ASND) |
Denmark |
$7.847B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$7.845B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$7.839B |
0.00 |
Acceleron Pharma (XLRN) |
United States |
$7.738B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$7.385B |
234.77 |
Exelixis (EXEL) |
United States |
$6.967B |
63.80 |
Sarepta Therapeutics (SRPT) |
United States |
$6.734B |
0.00 |
Adaptive Biotechnologies (ADPT) |
United States |
$5.879B |
0.00 |
Vir Biotechnology (VIR) |
United States |
$5.776B |
0.00 |
Twist Bioscience (TWST) |
United States |
$5.718B |
0.00 |
Blueprint Medicines (BPMC) |
United States |
$5.560B |
18.31 |
Halozyme Therapeutics (HALO) |
United States |
$5.534B |
45.46 |
Galapagos (GLPG) |
Belgium |
$5.475B |
0.00 |
Biohaven Pharmaceutical Holding (BHVN) |
United States |
$5.203B |
0.00 |
NeoGenomics (NEO) |
United States |
$5.058B |
617.86 |
Emergent Biosolutions (EBS) |
United States |
$4.920B |
11.76 |
SWEDISH ORP BIO (BIOVF) |
Sweden |
$4.791B |
15.07 |
China Biologic Products (CBPO) |
China |
$4.635B |
30.04 |
Arena Pharmaceuticals (ARNA) |
United States |
$4.439B |
0.00 |
Reata Pharmaceuticals (RETA) |
United States |
$4.330B |
0.00 |
Beam Therapeutics (BEAM) |
United States |
$4.208B |
0.00 |
Certara (CERT) |
United States |
$4.034B |
0.00 |
Insmed (INSM) |
United States |
$3.929B |
0.00 |
Apellis Pharmaceuticals (APLS) |
United States |
$3.923B |
0.00 |
SpringWorks Therapeutics (SWTX) |
United States |
$3.644B |
0.00 |
I-Mab (IMAB) |
China |
$3.546B |
0.00 |
Arvinas (ARVN) |
United States |
$3.521B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$3.509B |
0.00 |
Legend Biotech (LEGN) |
United States |
$3.235B |
0.00 |
Berkeley Lights (BLI) |
United States |
$3.202B |
0.00 |
MorphoSys AG (MOR) |
Germany |
$3.184B |
115.24 |
Alkermes (ALKS) |
Ireland |
$3.070B |
0.00 |
NantKwest (NK) |
United States |
$2.930B |
0.00 |
Viela Bio (VIE) |
United States |
$2.910B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$2.805B |
0.00 |
Editas Medicine (EDIT) |
United States |
$2.804B |
0.00 |
Amicus Therapeutics (FOLD) |
United States |
$2.770B |
0.00 |
Global Blood Therapeutics (GBT) |
United States |
$2.546B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$2.494B |
0.00 |
Deciphera Pharmaceuticals (DCPH) |
United States |
$2.466B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$2.411B |
0.00 |
Ligand Pharmaceuticals (LGND) |
United States |
$2.399B |
45.41 |
Amarin (AMRN) |
Ireland |
$2.329B |
0.00 |
Morphic Holding (MORF) |
United States |
$2.273B |
0.00 |
PHARMA MAR SA (PHMMF) |
Spain |
$2.211B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$2.094B |
0.00 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$2.091B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.083B |
17.25 |
Vericel (VCEL) |
United States |
$1.954B |
850.20 |
Bluebird Bio (BLUE) |
United States |
$1.926B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$1.908B |
0.00 |
Revance Therapeutics (RVNC) |
United States |
$1.877B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$1.801B |
0.00 |
Genetron Holdings (GTH) |
China |
$1.784B |
0.00 |
NGM Biopharmaceuticals (NGM) |
United States |
$1.781B |
0.00 |
Pandion Therapeutics (PAND) |
United States |
$1.768B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$1.739B |
0.00 |
Precigen (PGEN) |
United States |
$1.738B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.697B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$1.627B |
0.00 |
Heska (HSKA) |
United States |
$1.627B |
0.00 |
Travere Therapeutics (TVTX) |
United States |
$1.626B |
0.00 |
ADC Therapeutics SA (ADCT) |
Switzerland |
$1.567B |
0.00 |
Zymeworks (ZYME) |
Canada |
$1.520B |
0.00 |
UniQure (QURE) |
Netherlands |
$1.461B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$1.436B |
0.00 |
Nurix Therapeutics (NRIX) |
United States |
$1.421B |
0.00 |
Y-mAbs Therapeutics (YMAB) |
United States |
$1.421B |
0.00 |
Cytokinetics (CYTK) |
United States |
$1.399B |
0.00 |
Forma Therapeutics Holdings (FMTX) |
United States |
$1.394B |
0.00 |
Castle Biosciences (CSTL) |
United States |
$1.390B |
0.00 |
Alector (ALEC) |
United States |
$1.359B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$1.345B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$1.271B |
0.00 |
Frequency Therapeutics (FREQ) |
United States |
$1.261B |
0.00 |
Codexis (CDXS) |
United States |
$1.256B |
0.00 |
MiMedx (MDXG) |
United States |
$1.175B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.152B |
9.37 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.141B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$1.136B |
0.00 |
Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.135B |
0.00 |
Pliant Therapeutics (PLRX) |
United States |
$1.118B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$1.114B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$1.095B |
0.00 |
Adverum Biotechnologies (ADVM) |
United States |
$1.087B |
0.00 |
Mesoblast (MESO) |
Australia |
$1.078B |
0.00 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.062B |
0.00 |
Celldex Therapeutics (CLDX) |
United States |
$1.037B |
0.00 |
Avid Bioservices (CDMO) |
United States |
$1.007B |
0.00 |
Repare Therapeutics (RPTX) |
Canada |
$1.002B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$1.001B |
42.43 |
Epizyme (EPZM) |
United States |
$0.968B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.964B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$0.932B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.921B |
0.00 |
MannKind (MNKD) |
United States |
$0.907B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$0.902B |
226.13 |
G1 THERAPEUTICS (GTHX) |
United States |
$0.857B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.855B |
0.00 |
Pharming Group (PHAR) |
|
$0.852B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.822B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$0.817B |
21.75 |
Sutro Biopharma (STRO) |
United States |
$0.815B |
0.00 |
AnaptysBio (ANAB) |
United States |
$0.806B |
0.00 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.796B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.792B |
0.00 |
Cellectis S.A (CLLS) |
France |
$0.778B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.748B |
0.00 |
Merus (MRUS) |
Netherlands |
$0.719B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.713B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$0.682B |
0.00 |
ALBIREO PHARMA (ALBO) |
United States |
$0.666B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.663B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$0.658B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
Starpharma Holdings (SPHRY) |
Australia |
$0.626B |
0.00 |
Agenus (AGEN) |
United States |
$0.608B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.604B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.583B |
0.00 |
DBV Technologies S.A (DBVT) |
France |
$0.572B |
0.00 |
Compugen (CGEN) |
Israel |
$0.568B |
0.00 |
MeiraGTx Holdings (MGTX) |
United States |
$0.559B |
0.00 |
Geron (GERN) |
United States |
$0.559B |
0.00 |
Curis (CRIS) |
United States |
$0.557B |
0.00 |
Inventiva S.A (IVA) |
France |
$0.545B |
0.00 |
AC Immune SA (ACIU) |
Switzerland |
$0.533B |
0.00 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.526B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.512B |
0.00 |
Neoleukin Therapeutics (NLTX) |
United States |
$0.510B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.510B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.504B |
0.00 |
Amryt Pharma (AMYT) |
United Kingdom |
$0.501B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.492B |
164.95 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.489B |
0.00 |
AMMO (POWW) |
United States |
$0.475B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$0.463B |
0.00 |
Affimed (AFMD) |
Germany |
$0.461B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.451B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.448B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.444B |
0.00 |
Kala Pharmaceuticals (KALA) |
United States |
$0.438B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.437B |
0.00 |
UROGEN PHARMA (URGN) |
United States |
$0.415B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.410B |
19.29 |
Selecta Biosciences (SELB) |
United States |
$0.409B |
0.00 |
XOMA (XOMA) |
United States |
$0.407B |
0.00 |
Athenex (ATNX) |
United States |
$0.403B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.395B |
0.00 |
Fulcrum Therapeutics (FULC) |
United States |
$0.392B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.385B |
0.00 |
Opthea (OPT) |
Australia |
$0.385B |
0.00 |
Verastem (VSTM) |
United States |
$0.377B |
0.00 |
Kaleido Biosciences (KLDO) |
|
$0.374B |
0.00 |
Athersys (ATHX) |
United States |
$0.366B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.365B |
9.28 |
Cardiff Oncology (CRDF) |
United States |
$0.360B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.348B |
0.00 |
Forte Biosciences (FBRX) |
United States |
$0.343B |
0.00 |
Innate Pharma S.A (IPHA) |
France |
$0.340B |
0.00 |
Trevena (TRVN) |
United States |
$0.328B |
0.00 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.324B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.323B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.316B |
0.00 |
Arbutus Biopharma (ABUS) |
United States |
$0.315B |
0.00 |
NextCure (NXTC) |
United States |
$0.312B |
0.00 |
Bellus Health (BLU) |
Canada |
$0.301B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.295B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.282B |
0.00 |
Kamada (KMDA) |
Israel |
$0.272B |
15.64 |
HOOKIPA Pharma (HOOK) |
United States |
$0.260B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.258B |
0.00 |
CorMedix Inc (CRMD) |
United States |
$0.237B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.236B |
0.00 |
Cerecor (CERC) |
United States |
$0.232B |
0.00 |
ProQR Therapeutics (PRQR) |
Netherlands |
$0.232B |
0.00 |
TELA Bio (TELA) |
United States |
$0.232B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.225B |
0.00 |
OSMOTICA PHARM (OSMT) |
United States |
$0.223B |
0.00 |
INmune Bio (INMB) |
United States |
$0.214B |
0.00 |
Voyager Therapeutics (VYGR) |
United States |
$0.208B |
5.82 |
Applied Genetic Technologies (AGTC) |
United States |
$0.208B |
0.00 |
Aptinyx (APTX) |
United States |
$0.202B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.198B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.198B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.197B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.193B |
0.00 |
Evofem Biosciences (EVFM) |
United States |
$0.190B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.189B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.188B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.188B |
0.00 |
Nymox Pharmaceutical (NYMX) |
Canada |
$0.188B |
0.00 |
Eton Pharmaceuticals (ETON) |
United States |
$0.187B |
0.00 |
Exicure (XCUR) |
United States |
$0.180B |
0.00 |
Chiasma (CHMA) |
United States |
$0.178B |
0.00 |
Nicox SA (NICXF) |
France |
$0.177B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.176B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.173B |
358.50 |
Antibe Therapeutics (ATBPF) |
Canada |
$0.168B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.161B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.157B |
0.00 |
X4 Pharmaceuticals (XFOR) |
United States |
$0.155B |
0.00 |
Cogent Biosciences (COGT) |
United States |
$0.154B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.153B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.144B |
0.00 |
Biofrontera AG (BFRA) |
Germany |
$0.143B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.142B |
0.00 |
Seelos Therapeutics (SEEL) |
United States |
$0.139B |
0.00 |
Dyadic (DYAI) |
United States |
$0.136B |
0.00 |
Aytu Bioscience (AYTU) |
United States |
$0.133B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.130B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.127B |
0.00 |
CytRx (CYTR) |
United States |
$0.127B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.126B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.124B |
0.00 |
Liminal BioSciences (LMNL) |
Canada |
$0.123B |
0.00 |
Cyclerion Therapeutics (CYCN) |
United States |
$0.122B |
0.00 |
Synlogic (SYBX) |
United States |
$0.119B |
0.00 |
Evogene (EVGN) |
Israel |
$0.118B |
0.00 |
Beyond Air (XAIR) |
United States |
$0.116B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.116B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.113B |
0.00 |
Cidara Therapeutics (CDTX) |
United States |
$0.111B |
0.00 |
Lumos Pharma (LUMO) |
United States |
$0.109B |
0.00 |
Ecology Coatings (ABVC) |
United States |
$0.107B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.105B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.104B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.100B |
0.00 |
Cocrystal Pharma (COCP) |
United States |
$0.097B |
0.00 |
Adocia (ADOCY) |
France |
$0.092B |
0.00 |
Novogen (KZIA) |
Australia |
$0.090B |
0.00 |
AIkido Pharma (AIKI) |
United States |
$0.087B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.087B |
0.00 |
Stealth BioTherapeutics (MITO) |
United States |
$0.079B |
35.75 |
Cleveland BioLabs (CBLI) |
United States |
$0.077B |
0.00 |
Advaxis (ADXS) |
United States |
$0.076B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.076B |
0.00 |
CollPlant Biotechnologies (CLGN) |
Israel |
$0.074B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.069B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.068B |
0.00 |
Edesa Biotech (EDSA) |
Canada |
$0.067B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.066B |
0.00 |
Purple Biotech (PPBT) |
Israel |
$0.065B |
0.00 |
AnPac Bio-Medical Science (ANPC) |
China |
$0.065B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.064B |
0.00 |
Celsion (CLSN) |
United States |
$0.064B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.062B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.059B |
0.00 |
ZIVO Bioscience (ZIVO) |
United States |
$0.059B |
0.00 |
ARIDIS PHARMACT (ARDS) |
United States |
$0.056B |
0.00 |
Happiness Biotech Group (HAPP) |
China |
$0.048B |
0.00 |
Soligenix (SNGX) |
United States |
$0.048B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.045B |
0.00 |
Yumanity Therapeutics (YMTX) |
United States |
$0.044B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.044B |
0.00 |
BioCardia (BCDA) |
United States |
$0.044B |
0.00 |
ATyr Pharma (LIFE) |
United States |
$0.043B |
0.00 |
Enveric Biosciences (ENVB) |
United States |
$0.043B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.042B |
0.74 |
Alimera Sciences (ALIM) |
United States |
$0.038B |
0.00 |
Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.036B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.035B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.031B |
0.00 |
Lexaria Bioscience (LEXX) |
Canada |
$0.028B |
0.00 |
Seneca Biopharma (SNCA) |
United States |
$0.021B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.020B |
0.00 |
GeoVax Labs (GOVX) |
United States |
$0.019B |
0.00 |
ThermoGenesis Holdings (THMO) |
United States |
$0.019B |
0.00 |
Invo BioScience (INVO) |
United States |
$0.017B |
0.00 |
Benitec Biopharma (BNTC) |
United States |
$0.013B |
0.00 |
Cyclo Therapeutics (CYTH) |
United States |
$0.013B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |